Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers
Clinical trial NCT02362789 · COMPLETED
Trial details
- NCT number
- NCT02362789
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-04
- Primary completion
- 2016-07-15
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.